epigallocatechin gallate has been researched along with Immunoglobulin Light-chain Amyloidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Caaveiro, JMM; Matsunaga, E; Takahashi, D; Ueda, T; Yamashita, T | 1 |
| Goto, M; Hotta, M; Kobayashi, M; Meshitsuka, S; Nojima, M; Sagesaka, YM; Shingaki, S; Suzuki, K; Ukawa, Y; Wada, Y | 1 |
1 trial(s) available for epigallocatechin gallate and Immunoglobulin Light-chain Amyloidosis
| Article | Year |
|---|---|
Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Antioxidants; Catechin; Female; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Tea; Treatment Outcome | 2017 |
1 other study(ies) available for epigallocatechin gallate and Immunoglobulin Light-chain Amyloidosis
| Article | Year |
|---|---|
Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis.
Topics: Amyloid; Antioxidants; Catechin; Dose-Response Relationship, Drug; Flavonoids; Humans; Immunoglobulin lambda-Chains; Immunoglobulin Light-chain Amyloidosis; Kinetics; Magnetic Resonance Spectroscopy; Molecular Structure; Mutation; Protein Binding; Protein Stability; Quercetin; Time Factors | 2022 |